CG Oncology, Inc. Common stockCGONNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-114.63M
↓ 111% below average
Average (3y)
$-54.42M
Historical baseline
Range
High:$-12.38M
Low:$-114.63M
CAGR
+110.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-114.63M | -106.8% |
| 2023 | $-55.43M | -57.3% |
| 2022 | $-35.23M | -184.6% |
| 2021 | $-12.38M | - |